The iImplantable Venous Access Port, also known as PORT in the clinic, is a professional infusion device that is placed in the body to reduce the vascular irritation of the drug. It is divided into three parts: a non-invasive needle (butterfly needle), a catheter placed in the subclavian vein, and an injection seat (port body) buried under the skin and connected to the infusion needle. The injection seat is connected to the catheter inserted into the subclavian vein to form a long-term vascular access, which acts like a port, so it is called an "infusion port."

The global Implantable Venous Access Port market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Implantable Venous Access Port volume and value at global level, regional level and company level. From a global perspective, this report represents overall Implantable Venous Access Port market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
BD
Smiths Medical
Teleflex
B. Braun
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Polyurethane Catheter
Silicone Catheter
Other

Segment by Application
Front Chest
Under the Collarbone